Immunology

Monkeypox: What is known and unknown

The current outbreak of monkeypox is showing no sign of slowing. Stuart Isaacs of the Perelman School of Medicine, an expert on poxviruses, sheds light on the disease, its prevention and treatment, and what to watch for this fall.

Katherine Unger Baillie



In the News


Forbes

$50 million gift to University of Pennsylvania for autoimmune disease research

A $50 million gift from Wharton School alumni Judy and Stewart Colton will further develop the work of the Colton Center for Autoimmunity at the Perelman School of Medicine, with a statement from President Liz Magill.

FULL STORY →



Philadelphia Inquirer

$50 million gift to Penn is aimed at new treatments for autoimmune disease

E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton.

FULL STORY →



The New York Times

Scientists have made a human microbiome from scratch

Gary Wu of the Perelman School of Medicine comments on the importance of the new creation of a synthetic human microbiome.

FULL STORY →



The New York Times

The many uses of CRISPR: Scientists tell all

Carl June and Ed Stadtmauer comment on the last decade’s revolution in the treatment of diseases.

FULL STORY →



Chemistry World

A decade of CAR T cell therapy 

In a feature on the history and future of CAR T, the work of Carl June, Michael C. Milone, Aimee Payne, Drew Weissman, and Jonathan Epstein from the Perelman School of Medicine is highlighted.

FULL STORY →



Technology Networks

CAR T cells engineered to deliver RNA to enhance immunotherapy response

Andy J. Minn of the Perelman School of Medicine explains how Chimeric antigen receptor T cells typically are like lone soldiers without backup.

FULL STORY →